Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | SVP,Head Glob. Medical Affairs | June 03, 2021 | June 04, 2021 |
| GERON CORPGERN · Entity 4989 | EVP, R&D; Chief Medical Office | February 17, 2026 | February 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRISTOL MYERS SQUIBB CO
Report date June 03, 2021 · Filed June 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Direct | 9,485 |
Ending reported balance
After 2021-06-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-06-03 · Exercise / conversion · Acquired 2,154 · Balance 10,223 F1: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. F2: Each restricted stock unit converts into one share of common stock upon vesting. Row 2 · 2021-06-03 · Tax withholding · Disposed 738 · Balance 9,485 F3: Shares withheld for payment of taxes upon vesting. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2023-06-03 | Direct | 4,309 |
Reported balance
After 2021-06-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-06-03 · Exercise / conversion · Disposed 2,154 · Balance 4,309 F2: Each restricted stock unit converts into one share of common stock upon vesting. F1: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020.
F2: Each restricted stock unit converts into one share of common stock upon vesting.
F3: Shares withheld for payment of taxes upon vesting.
GERON CORP
Report date February 17, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.80 · Expires 2036-02-16 | Direct | 2,220,000 |
Reported balance
After 2026-02-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-17 · Grant · Acquired 2,220,000 · Balance 2,220,000 F1: The option vests in 48 equal monthly installments commencing on March 17, 2026, provided that the Reporting Person provides continuous service to the Issuer on each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in 48 equal monthly installments commencing on March 17, 2026, provided that the Reporting Person provides continuous service to the Issuer on each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2026 Filed Feb 19, 2026 23:11 UTC | GERON CORP GERN · Entity 4989 | GrantStock Option (Right to Buy) · Derivative | 2,220,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001780247-26-000001 · form4-02192026_110212.xml · derivative · entry 1 Eid Joseph · CIK 0001780247 · EVP, R&D; Chief Medical Office 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,220,000 Underlying: Common Stock · 2,220,000 shares Expires 2036-02-16 F1 · derivative.exercise_date: The option vests in 48 equal monthly installments commencing on March 17, 2026, provided that the Reporting Person provides continuous service to the Issuer on each such vesting date. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 21:05 UTC | GERON CORP GERN · Entity 4989 | GrantStock Option (right to buy) · Derivative | 2,500,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000950170-24-125325 · ownership.xml · derivative · entry 1 Eid Joseph · CIK 0001780247 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500,000 Underlying: Common Stock · 2,500,000 shares Expires 2034-11-10 F1 · derivative.exercise_date: The options vest as follows: 312,500 shares on May 11, 2025, the remaining 2,187,500 shares in series of 42 equal monthly installments commencing May 11, 2025, provided the optionee continues to provide services to the Company. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 20:36 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 2,154 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000145 · wf-form4_162283895580715.xml · derivative · entry 3 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,309 Underlying: Common Stock, $0.10 par value · 2,154 shares Expires 2023-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · shares: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. F1 · derivative.exercise_date: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. F1 · derivative.expiration_date: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 20:36 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 738 | $64.80 | $47,822.40 |
DisclosureSEC source: 0000014272-21-000145 · wf-form4_162283895580715.xml · nonDerivative · entry 2 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,485 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 20:36 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,154 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000145 · wf-form4_162283895580715.xml · nonDerivative · entry 1 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. F2 · price: Each restricted stock unit converts into one share of common stock upon vesting. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 1,118 | $65.00 | $72,670.00 |
DisclosureSEC source: 0000014272-21-000136 · wf-form4_162076555486017.xml · nonDerivative · entry 1 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,069 Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 4,898 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · derivative · entry 18 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,898 Underlying: Common Stock, $0.10 par value · 4,898 shares Expires 2024-03-10 F12 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2024. F12 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2024. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 3,751 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · derivative · entry 17 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 3,751 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2021, subject to a Total Shareholder Return. F11 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2021, subject to a Total Shareholder Return. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 3,265 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · derivative · entry 16 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,265 Underlying: Common Stock, $0.10 par value · 3,265 shares Expires 2025-03-10 F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F10 · derivative.exercise_date: Twenty-five percent of these market share units will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · derivative · entry 15 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,438 Underlying: Common Stock, $0.10 par value · 812 shares Expires 2024-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F6 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2020. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 946 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · derivative · entry 14 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,892 Underlying: Common Stock, $0.10 par value · 946 shares Expires 2023-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2019. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · derivative · entry 13 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626 Underlying: Common Stock, $0.10 par value · 625 shares Expires 2022-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2018. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,405 | $60.93 | $85,606.65 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · nonDerivative · entry 12 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,187 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 730 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · nonDerivative · entry 11 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,592 F8 · shares: Adjustment to Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,751 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · nonDerivative · entry 10 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Amount represents distribution of performance shares earned under the 2018-2020 Long-Term Performance Award. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 260 | $60.93 | $15,841.80 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · nonDerivative · entry 9 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,111 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · nonDerivative · entry 8 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,371 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · nonDerivative · entry 7 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2020. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 348 | $60.93 | $21,203.64 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · nonDerivative · entry 6 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,544 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 164 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · nonDerivative · entry 5 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,892 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 946 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · nonDerivative · entry 4 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2019. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 179 | $60.93 | $10,906.47 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · nonDerivative · entry 3 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,782 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 55 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · nonDerivative · entry 2 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,961 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000093 · wf-form4_161559346533031.xml · nonDerivative · entry 1 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2018. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 22:15 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 2,825 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000291 · wf-form4_160703370404217.xml · derivative · entry 3 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock, $0.10 par value · 2,825 shares Expires 2021-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · derivative.exercise_date: The restricted stock unit vests in four equal annual installments beginning on December 1, 2018. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 22:15 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 968 | $62.41 | $60,412.88 |
DisclosureSEC source: 0000014272-20-000291 · wf-form4_160703370404217.xml · nonDerivative · entry 2 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,391 F2 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 22:15 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,825 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000291 · wf-form4_160703370404217.xml · nonDerivative · entry 1 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit vests in four equal annual installments beginning on December 1, 2018. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 22:15 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 5,327 | $64.00 | $340,928.00 |
DisclosureSEC source: 0000014272-20-000233 · wf-form4_159787532506693.xml · nonDerivative · entry 1 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,534 Read SEC document |
| June 03, 2020 Filed Jun 9, 2020 23:15 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 2,154 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000181 · wf-form4_159174451571136.xml · derivative · entry 3 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,463 Underlying: Common Stock, $0.10 par value · 2,154 shares Expires 2023-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F4 · date: Due to an administrative error, this Form 4 was not timely filed. F1 · shares: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. F1 · derivative.exercise_date: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. F1 · derivative.expiration_date: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. Read SEC document |
| June 03, 2020 Filed Jun 9, 2020 23:15 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 738 | $60.21 | $44,434.98 |
DisclosureSEC source: 0000014272-20-000181 · wf-form4_159174451571136.xml · nonDerivative · entry 2 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,861 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| June 03, 2020 Filed Jun 9, 2020 23:15 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,154 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000181 · wf-form4_159174451571136.xml · nonDerivative · entry 1 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. F2 · price: Each restricted stock unit converts into one share of common stock upon vesting. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 4,875 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000118 · wf-form4_158405119994754.xml · derivative · entry 10 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,875 Underlying: Common Stock, $0.10 par value · 4,875 shares Expires 2023-03-10 F8 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2023. F8 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2023. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 3,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000118 · wf-form4_158405119994754.xml · derivative · entry 9 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,250 Underlying: Common Stock, $0.10 par value · 3,250 shares Expires 2024-03-10 F6 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F7 · derivative.exercise_date: Twenty-five percent of these market share units will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 946 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000118 · wf-form4_158405119994754.xml · derivative · entry 8 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,838 Underlying: Common Stock, $0.10 par value · 946 shares Expires 2023-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2019. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000118 · wf-form4_158405119994754.xml · derivative · entry 7 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,251 Underlying: Common Stock, $0.10 par value · 625 shares Expires 2022-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2018. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 419 | $57.93 | $24,272.67 |
DisclosureSEC source: 0000014272-20-000118 · wf-form4_158405119994754.xml · nonDerivative · entry 6 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,445 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000118 · wf-form4_158405119994754.xml · nonDerivative · entry 5 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,864 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 946 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000118 · wf-form4_158405119994754.xml · nonDerivative · entry 4 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2019. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 216 | $57.93 | $12,512.88 |
DisclosureSEC source: 0000014272-20-000118 · wf-form4_158405119994754.xml · nonDerivative · entry 3 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,706 F3 · shares: Shares withheld for payment of taxes upon vesting. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000118 · wf-form4_158405119994754.xml · nonDerivative · entry 2 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,922 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000118 · wf-form4_158405119994754.xml · nonDerivative · entry 1 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2018. Read SEC document |
| December 01, 2019 Filed Dec 3, 2019 22:28 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 2,825 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000233 · wf-form4_157541211408099.xml · derivative · entry 3 Eid Joseph · CIK 0001780247 · SVPHead Global Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Common Stock, $0.10 par value · 2,825 shares Expires 2021-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit coverts into one share of common stock upon vesting. F1 · shares: The restricted stock unit vests in four equal annual installments beginning on December 1, 2018. F1 · derivative.exercise_date: The restricted stock unit vests in four equal annual installments beginning on December 1, 2018. F1 · derivative.expiration_date: The restricted stock unit vests in four equal annual installments beginning on December 1, 2018. Read SEC document |
| December 01, 2019 Filed Dec 3, 2019 22:28 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 968 | $56.94 | $55,117.92 |
DisclosureSEC source: 0000014272-19-000233 · wf-form4_157541211408099.xml · nonDerivative · entry 2 Eid Joseph · CIK 0001780247 · SVPHead Global Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,027 F2 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| December 01, 2019 Filed Dec 3, 2019 22:28 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,825 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000233 · wf-form4_157541211408099.xml · nonDerivative · entry 1 Eid Joseph · CIK 0001780247 · SVPHead Global Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit vests in four equal annual installments beginning on December 1, 2018. Read SEC document |
| December 01, 2019 Filed Mar 12, 2020 22:13 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 2,825 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000117 · wf-form4a_158405117849751.xml · derivative · entry 3 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Common Stock, $0.10 par value · 2,825 shares Expires 2021-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit coverts into one share of common stock upon vesting. F1 · shares: The restricted stock unit vests in four equal annual installments beginning on December 1, 2018. F1 · derivative.exercise_date: The restricted stock unit vests in four equal annual installments beginning on December 1, 2018. F1 · derivative.expiration_date: The restricted stock unit vests in four equal annual installments beginning on December 1, 2018. Read SEC document |
| December 01, 2019 Filed Mar 12, 2020 22:13 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 968 | $56.94 | $55,117.92 |
DisclosureSEC source: 0000014272-20-000117 · wf-form4a_158405117849751.xml · nonDerivative · entry 2 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,327 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| December 01, 2019 Filed Mar 12, 2020 22:13 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,825 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000117 · wf-form4a_158405117849751.xml · nonDerivative · entry 1 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit vests in four equal annual installments beginning on December 1, 2018. F2 · balance_after: Due to an administrative error, 1,300 shares were inadvertently omitted from the Form 4 filed on December 3, 2019. This amendment is being filed to include such shares. All other information set forth in the December 3, 2019 Form 4 remains correct. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.